CASI Pharmaceuticals Inc
General ticker "CASI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $53.3M
CASI Pharmaceuticals Inc follows the US Stock Market performance with the rate: 2.8%.
Estimated limits based on current volatility of 8.7%: low 2.47$, high 2.95$
Factors to consider:
- Current price 30.0% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [4.03$, 9.41$]
- 2024-12-30 to 2025-12-30 estimated range: [3.83$, 8.89$]
Short-term CASI quotes
Long-term CASI plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $30.17MM | $43.11MM | $33.88MM |
| Operating Expenses | $72.00MM | $69.60MM | $58.96MM |
| Operating Income | $-41.84MM | $-26.49MM | $-25.08MM |
| Non-Operating Income | $6.00MM | $-10.94MM | $-1.21MM |
| Interest Expense | $0.00MM | $28.98MM | $0.00MM |
| R&D Expense | $14.42MM | $16.00MM | $9.86MM |
| Income(Loss) | $-35.84MM | $-37.43MM | $-26.29MM |
| Taxes | $0.00MM | $1.98MM | $0.65MM |
| Profit(Loss) | $-35.84MM | $-39.41MM | $-26.94MM |
| Stockholders Equity | $84.50MM | $44.57MM | $24.16MM |
| Inventory | $1.91MM | $6.14MM | $15.88MM |
| Assets | $138.30MM | $96.23MM | $75.27MM |
| Operating Cash Flow | $-26.84MM | $-21.09MM | $-19.97MM |
| Capital expenditure | $15.50MM | $5.61MM | $2.24MM |
| Investing Cash Flow | $-20.69MM | $31.16MM | $-9.67MM |
| Financing Cash Flow | $29.64MM | $-3.27MM | $-0.91MM |
| Earnings Per Share* | $-2.78 | $-2.89 | $-2.02 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.